CAMBRIDGE, Mass. and HEIDELBERG, Germany--(BUSINESS WIRE)--Feb. 3, 2005--
LION bioscience today announced revenues for the third quarter of fiscal year (FY) 2004/2005 of EUR 2.2 m, compared with EUR 5.8 m in the same period last year. Net loss for the quarter was reduced to EUR (3.2) m compared with EUR (6.3) m in Q3 of FY 2003/2004.
